Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
Joanna Szarmach, Wiesław Jerzy Cubała, Adam Włodarczyk, Maria Gałuszko-Węgielnik Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, PolandCorrespondence: Adam WłodarczykDepartment of Psychiatry, Faculty of Medicine, Medical University of Gdansk, 7 Dębinki Street, Bu...
Enregistré dans:
Auteurs principaux: | Szarmach J, Cubała WJ, Włodarczyk A, Gałuszko-Węgielnik M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8d07512b47d94545a84773e3bcc5a44d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
par: Wilkowska A, et autres
Publié: (2021) -
Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
par: Maria Gałuszko-Wȩgielnik, et autres
Publié: (2021) -
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
par: Wei Zheng, et autres
Publié: (2021) -
Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
par: F Kheirkhah, et autres
Publié: (2010) -
Ketamine in Bipolar Disorder: A Review
par: Wilkowska A, et autres
Publié: (2020)